Drugs / SN2001
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07059403 | Aug 2025 → Apr 2027 expected | chronic hepatitis B virus infection | Chimivac INC | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SN2001 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07059403 ↗ |
| Route | Subcutaneous | “for subcutaneous (SC) injection” NCT07059403 ↗ |